# Sildenafil Citrate and Intrapartum Fetal Distress

> **NCT04325243** · PHASE4 · COMPLETED · sponsor: **Assiut University** · enrollment: 410 (actual)

## Conditions studied

- Fetal Distress

## Interventions

- **DRUG:** Sildenafil 50 mg
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04325243
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-01
- **Primary completion:** 2022-04-30
- **Final completion:** 2022-07-31
- **Target enrollment:** 410 (ACTUAL)
- **Last updated:** 2023-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04325243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04325243, "Sildenafil Citrate and Intrapartum Fetal Distress". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04325243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*